Arcturus Therapeutics Arcturus Therapeutics is a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines. We have proprietary technologies, validating partnerships, and an experienced team with deep expertise in delivery and RNA-based therapeutics Corporate Deck DOWNLOAD U.S. Headquarters Global Multicultural Team VIEW COVID-19 Vaccine using STARR™ LEARN MORE News & Events November 22, 2021 Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference READ MORE November 18, 2021 Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) READ MORE November 8, 2021 Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress READ MORE October 25, 2021 Arcturus Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on November 8, 2021 READ MORE October 21, 2021 Arcturus Therapeutics Announces Leadership Appointments READ MORE October 20, 2021 Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) READ MORE LUNAR® Mechanism of Delivery Home Contact Careers Terms and Conditions Privacy Policy © 2021 Arcturus Therapeutics, Inc.